-
Lights out in Laos as electricity exports surge
-
Anthropic details Claude misuse as US targets major illicit online marketplace
-
Steven Strogatz weighs AI mathematics advances and their consequences for researchers
-
Venezuelans outside Caracas say capital not sharing blackout burden
-
Anthropic boss calls for AI slowdown, Altman and Musk agree
-
Anthropic boss calls for slowing pace of AI development
-
French IT giant Capgemini sells subsidiary after row over ICE links
-
BRICS nations urge 'maximum restraint' in Middle East war
-
Quebec Brokerage Qubit Insurance Announces New Data on Coverage Shortfalls as Rebuilding Costs Rise
-
Europe eyes battle over 'pervert' AI glasses
-
Lady Gaga welcomes first child with fiance: US media
-
Children in flood-hit Nepal grapple with loss, cling to hope
-
Bhutan business bets on hazelnuts for farming future
-
Venice Film Festival: A look back on the highlights
-
'Widow's Bay' and 'The Pitt' are favorites for Emmys night
-
DR Congo school fire stampede death toll rises to 26: UNICEF
-
Coastal erosion forces cancellation of California music festival
-
Dance Fitness Tempe Announces Expansion of Accessible Digital Movement Programs
-
Argentina's Dirty War rears its head in Venice film
-
Europe saw record summer air traffic despite Mideast war: Eurocontrol
-
UK lawmakers throw out bill to legalise assisted dying
-
Relatives of 9/11 victims hit out at Saudi Arabia -- and US leaders
-
US inflation steady in August, fueling Fed rate hike expectations
-
Relative of 9/11 victim unleashes searing attack on Saudi Arabia
-
New York marks 25th anniversary of 9/11 attacks
-
Czech antitrust office lets Turkey's Pegasus Airlines buy Smartwings
-
Nepal flood reconstruction bill to be $4.78 bn: foreign ministry
-
Investors on edge as energy costs, surging bond yields roil markets
-
JUMO and Standard Bank launch Social Finance Framework to scale inclusive finance in Africa
-
UK lawmakers to vote again on failed assisted dying bill
-
Doomsday tech: could AI really kill us all?
-
Yemen's Houthis complete takeover of Bab al-Mandab area: govt official to AFP
-
French comedy show 'Call my agent' makes film comeback
-
Fast-pace dance takes I.Coast's working-class streets by storm
-
It's all coming back: Celine Dion fans gear up for Paris return
-
Fans celebrate Celine Dion's Paris return with giant karaoke
-
Researchers eye AI revolution in natural disaster forecasts
-
Appreciation, anger await as Trump heads to Irish golf resort
-
US braces for inflation report that may push Fed to hike rates
-
Putin arrives in India for BRICS summit coloured by wars
-
Musk threatens legal action over documentary
-
Carney says in touch with Trump, Canada ready for 'fair' trade deal
-
Latin America fact-check group asks Meta not to replace verification practice
-
Tag Markets Names Craig Lund Chief Executive Officer
-
AI Risks to Enter 60–80% of Liability and Cyber Insurance Underwriting by 2028, ScienceSoft Predicts
-
ECB lifts borrowing costs amid energy shock, opens door for more hikes
-
Tribal Launches Campfire, Letting Business and Technical Teams Build on Salesforce Together
-
Global Tokenized Real Estate Market to Hit up to $3 Trillion by 2030, ScienceSoft Predicts
-
Stocks fall as fresh oil surge fans inflation fears
-
US producer inflation tops expectations as diesel costs jump
Adding peanuts to young children's diet can help avoid allergy: study
Including peanuts in children's diets early in life could help stave off allergies against the legume, which can be fatal and affect swathes of youngsters globally, according to a new study Friday.
Researchers found that introducing peanut products to babies and infants, and gradually increasing exposure, led to greater tolerance for the common allergen.
The peer-reviewed study, published in The Lancet, involved 146 peanut-allergic children aged between zero and three over two-and-a-half years.
Of the group, 96 were given peanut protein powder every day, with the dose increasing progressively to the equivalent of six peanuts. The other children received a placebo of oat flour.
Twenty of the children who received peanut powder showed allergy remission, meaning no allergic reaction occurred six months after the therapy ended.
One child in the placebo group showed remission.
Six months after the treatment, the children in remission could tolerate a dose equivalent to 16 peanuts.
An additional 20 children who received peanut powder were considered 'desensitised', meaning they had a higher allergic threshold but were not considered in remission.
These children could tolerate a dose equivalent to between six and 12 peanuts six months after the treatment ended.
The youngest children in the study experienced remission the most often, and the best results were in those under 12 months.
"Very early interventions may provide the best opportunity to achieve remission", said co-author Stacie Jones.
- 'Considerable burden' -
Peanut allergies affect two percent of children in Western countries, according to the study, and can last a lifetime.
Affected children must avoid eating peanuts and have self-injectable adrenaline available to fight allergic shocks, which can be fatal if they are accidentally exposed.
Exposure can even occur when a child hugs someone who has just consumed peanuts.
"There are no treatment options, resulting in a considerable burden on allergic children and their caregivers to avoid accidental exposure," said co-author Wesley Burks.
"In severe cases, this can restrict peanut-allergic children's freedoms, particularly when it comes to navigating daycare or schools and public spaces where access to a safe diet is in jeopardy," he added.
Previous studies have produced similar results but the length of the latest studies makes it unique.
Although it provided important results, it may not reflect the behaviour of the children's bodies in real-world conditions.
The study was conducted under close medical supervision, and adrenaline injections were administered on 21 children during the trial.
L.Peeters--CPN